Experts Discuss the Path Toward Overcoming Racial Health Disparities
Racial and ethnic minorities are disproportionately affected by virtually every major disease of our time, and this gap has only been exacerbated by COVID-19. This year,...
Video
68 Results
Clear Filters
Valentina Fossati Explains Why We Sent Patient Cells to Space
Cover photo: Dr. Valentina Fossati (NYSCF) and Jason Stein (Aspen Neuroscience) prepare cells for launch. Photo credit: Space Tango Why send cells affected by multiple sclerosis...
Tackling COVID, Promoting Health Equity, and Delivering on the Promise of Regenerative Medicine: Highlights of the 2020 NYSCF Conference
“My oldest son, Andrew, is a cancer survivor,” said Tony Coles, MD, PhD, CEO of Cerevel Therapeutics. “He was afflicted with non-Hodgkins lymphoma when he...
Showing Up for Science: Celebrities and Stem Cells Take Center Stage at the NYSCF Gala
Hosted by CNN’s Chief Medical Correspondent Sanjay Gupta, MD, this year’s New York Stem Cell Foundation Research Institute Gala & Science Fair went virtual for the...
Experts Discuss the Latest in COVID-19 Research: Everything from Immunity to Stem Cells to Vaccines
It has been six months since the COVID-19 pandemic hit the United States at full force, leaving millions sick, out of work, and desperate for new...
Does Brain Inflammation Trigger Neurodegeneration? If So, it Could Open the Door for New Therapies
Today, more than 6 million Americans suffer from neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and multiple sclerosis, and as our society ages, that number is only...
On the Road to Personalized Therapies for Women with Reproductive Cancers
Ovarian cancer is a difficult disease to tackle, as is evident from the statistics that surround it: Five years after diagnosis, ovarian cancer survival rates are...
All Your Questions About the Science of COVID-19, Answered – Plus How Stem Cells Can Help
Featured image credit: National Institute of Allergy and Infectious Diseases What makes the COVID-19 virus so hard to contain? Why do some people have severe reactions? What...
New Solutions Are on the Horizon for COVID-19: Here’s How the NYSCF Community is Uniting to Push Them Forward
The COVID-19 pandemic has upended society, leaving millions sick and out of work. Fortunately, scientists have started a global race to understand the virus, halt its...
Kay Tye Delivers TED Talk on the Underpinnings of Mental Illness
NYSCF – Robertson Neuroscience Investigator Alumna and Salk Institute Professor Kay Tye, PhD, recently delivered a TED Talk on her pioneering work to illuminate how circuits...
Progress, Challenges, and Promise: On the Road to a Type 1 Diabetes Cure
“How many people were promised a cure [for type 1 diabetes] within five or ten years?” JDRF CEO Aaron Kowalski asks the audience. Half the hands...
New Hope for Alzheimer’s: Scientists and Clinicians Present Emerging Therapies for a Notoriously Challenging Disease
Alzheimer’s remains one of the most devastating diseases in the world, and though there are more than 44 million people with it worldwide, there are still...
Gene Editing: The Science, Ethics, and Promise of a Revolutionary Technology
Perhaps in the past few years, you’ve started to hear more about CRISPR gene editing— the revolutionary technique that allows us to precisely manipulate the DNA...
Taking on Type 1 Diabetes: Researchers and Patient Advocates Unite in the Quest for a Cure
“I got involved in type one diabetes advocacy over 25 years ago when my son was diagnosed,” said NYSCF CEO Susan L. Solomon, JD. “At that...
Shifting Paradigms in Research and Treatment of Women’s Reproductive Cancers
Women’s reproductive cancers—such as ovarian cancer, endometrial cancer, uterine cancer, and cervical cancer—are especially difficult to treat. Mortality rates are high (32,000 women die from these...
NYSCF Collaboration Uncovers New Target for Progressive Multiple Sclerosis Therapies
The Context: In multiple sclerosis, the immune system attacks myelin (the fatty substance that surrounds neurons and helps them send signals). Currently, there are no...
NYSCF Hosts Panel Discussion on the Future of Alzheimer’s Research and Treatment
44 million people worldwide are affected by Alzheimer’s. 1 in 3 seniors will die with it or a related dementia. The cost of treating Alzheimer’s is...
NYSCF Scientists Make Progress Toward Clinical-Grade Bone
What They Did: A team of NYSCF scientists led by NYSCF – Ralph Lauren Senior Principal Investigator Dr. Giuseppe Maria de Peppo tested whether mesenchymal progenitor...
Why We Need Stem Cell Avatars: Susan Solomon Speaks at IGNITION Conference
“It takes 13 years—after you have sunk 4 billion dollars into a drug—to figure out whether or not it will succeed, and your chance of being...
NYSCF Researchers Develop Novel Bioengineering Technique for Personalized Bone Grafts
Scientists from the New York Stem Cell Foundation (NYSCF) Research Institute have developed a new bone engineering technique called Segmental Additive Tissue Engineering (SATE). The technique,...
Meet Elizabeth Schwarzbach, PhD, NYSCF Vice President of Business Development
With a background in pharmacology, drug discovery, and research and development strategy, in addition to extensive experience in both industry and academia, Liz will expand NYSCF’s...
Spotlighting International Multiple Sclerosis Awareness Month
NYSCF spoke with Dr. Valentina Fossati who leads NYSCF’s multiple sclerosis research on the future of MS treatments and how stem cells have changed the field...
Tenth Annual Gala and Science Fair
The Tenth Annual Gala began with an inside look at the NYSCF laboratory at the NYSCF Science Fair. This October, NYSCF honored Stephen M. Ross, Jack and...
Ninth Annual Gala and Science Fair
The Ninth Annual Gala began with an inside look at the NYSCF laboratory at the NYSCF Science Fair, designed by David Rockwell. Anne & Vincent Mai,...
SCNT – Susan Solomon and Dr. Dieter Egli Discuss NYSCF’s Latest Breakthrough
Dr. Dieter Egli, NYSCF Senior Research Fellow, discusses his latest somatic cell nuclear transfer (SCNT) research with NYSCF CEO Susan L. Solomon.